Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Zimmer hires former Nevro CEO Kevin Thornal
Medtech Dive
Wednesday, May 28, 2025 - 9:58am
tags:
Medtech, Zimmer Biomet, Kevin Thornal, Nevro
FDA approves use of Sanofi's meningococcal vaccine in infants
MSN/Reuters
Wednesday, May 28, 2025 - 9:52am
tags:
Sanofi, FDA, vaccines, meningococcal disease, infants, MenQuadfi
GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win
Fierce Biotech
Wednesday, May 28, 2025 - 9:46am
tags:
GSK, Spero Therapeutics, antibiotics, UTIs, tebipenem, clinical trials
With new Alzheimer’s blood test cleared, a potential vaccine could be on the horizon
Pharma Voice
Wednesday, May 28, 2025 - 9:41am
tags:
vaccines, Alzheimer's disease, Fujirebio Diagnostics, Nuravax, Duvax
Merck KGaA shares phase 3 rare tumor data ahead of showdown with Daiichi and Ono
Fierce Biotech
Wednesday, May 28, 2025 - 9:39am
tags:
Merck KGaA, clinical trials, tenosynovial giant cell tumors, pimicotinib, Daiichi Sankyo, Ono Pharmaceutical
BrainStorm Cell Therapeutics and Minaris partner on manufacturing NurOwn for trial
Clinical Trials Arena
Wednesday, May 28, 2025 - 9:37am
tags:
BrainStorm Cell Therapeutics, Minaris, NurOwn, clinical trials
FDA fast-tracks Teva's celiac disease treatment
Pharmaphorum
Wednesday, May 28, 2025 - 9:35am
tags:
Teva Pharmaceutical, FDA, celiac disease, fast track status
Private equity firms reportedly offer $16B-plus to acquire Hologic
Radiology Business
Wednesday, May 28, 2025 - 9:21am
tags:
Medtech, M&A, Radiology, Holologic
AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide
Fierce Pharma
Tuesday, May 27, 2025 - 10:19pm
tags:
AbbVie, Allergan Aesthetics, layoffs
FDA sets COVID vaccine formula as RFK Jr. narrows guidance for shots
BioPharma Dive
Tuesday, May 27, 2025 - 10:16pm
tags:
FDA, HHS, Robert F Kennedy Jr., vaccines, COVID-19
Gilgamesh links psychedelic to 94% remission rate in midphase depression trial
Fierce Biotech
Tuesday, May 27, 2025 - 10:13pm
tags:
Gilgamesh Pharmaceuticals, clinical trials, psychedelic drugs, depression, GM-2505
5 people charged in $600K insider trading scheme tied to Novartis' Chinook acquisition: DOJ
Fierce Biotech
Tuesday, May 27, 2025 - 10:11pm
tags:
Novartis, M&A, insider trading, Chinook Therapeutics
Abbott Celebrates Huge Win in TMVR Space
Medical Devices and Diagnostics Industry
Tuesday, May 27, 2025 - 10:10pm
tags:
Medtech, Abbott Labs, FDA, Tendyne, TMVR, Edwards Lifesciences, Sapien 3
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Yahoo/Investing.com
Tuesday, May 27, 2025 - 11:40am
tags:
Eli Lilly, M&A, SiteOne Therapeutics, non-opioid pain treatments
FDA Outlines AI Medical Device Software Recommendations in Draft Guidance
Medical Devices and Diagnostics Industry
Tuesday, May 27, 2025 - 11:37am
tags:
FDA, regulatory, artificial intelligence, Medtech
Rocket crashes as gene therapy patient dies, FDA imposes hold
Fierce Biotech
Tuesday, May 27, 2025 - 11:35am
tags:
Rocket Pharmaceuticals, gene therapy, patient death, FDA, Danon disease
FDA approves Susvimo for treatment of diabetic retinopathy
Healio
Tuesday, May 27, 2025 - 11:33am
tags:
Roche, Susvimo, diabetic retinopathy
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Fierce Biotech
Tuesday, May 27, 2025 - 11:27am
tags:
Biogen, RNAi, City Therapeutics, CNS
How Medtronic is Offsetting a $350M Tariff Burden
Medical Devices and Diagnostics Industry
Tuesday, May 27, 2025 - 11:25am
tags:
Medtech, Medtronic, tariffs, earnings
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
BioSpace
Tuesday, May 27, 2025 - 11:20am
tags:
Mehmet Oz, Donald Trump, drug pricing, most favored nation

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.